Baxter International, an American healthcare company, has received market approval in Europe for HOMECHOICE CLARIA, an automated peritoneal dialysis (APD) system.
The system is integrated with the SHARESOURCE web-based connectivity platform. According to the developer, the APD system is designed with user-friendly features and with secure two-way connectivity. The connectivity will help healthcare providers to monitor their patients' home peritoneal dialysis (PD) treatments and adjust prescriptions as necessary.
Dialysis
Dialysis is an artificial process for removing excess water and waste from the blood. Hemodialysis and peritoneal dialysis are the types of dialysis.
Advertisement
PD is a therapy option performed primarily at home by end-stage renal disease patients.
"CLARIA builds upon our market-leading HOMECHOICE APD device with new features to make the system more intuitive for patients to operate in their home and while traveling. Additionally, SHARESOURCE, the system's web-based platform, provides physicians remote access to their home patients' treatment information allowing for more timely and personalized care," said Bruce Culleton, M.D., vice president and renal therapeutic area lead at Baxter.
![Diabetic Kidney Disease]( "Diabetic Kidney Disease")
Diabetic nephropathy refers to kidney damage due very high levels of blood sugar levels in diabetics.
Baxter plans to initiate the commercial launch of the automated dialysis system in select European and Asian countries in the first half of 2015.
"Every patient with end-stage renal disease deserves access to individualized care. HOMECHOICE CLARIA with SHARESOURCE represents Baxter's continued commitment to advancing renal technology that offers healthcare providers and patients therapy options for end-stage renal disease," said Jill Schaaf, president of Baxter's Renal business.
Source: Medindia
Diabetic Kidney Disease
Diabetic nephropathy refers to kidney damage due very high levels of blood sugar levels in diabetics.
Advertisement
Baxter plans to initiate the commercial launch of the automated dialysis system in select European and Asian countries in the first half of 2015.
"Every patient with end-stage renal disease deserves access to individualized care. HOMECHOICE CLARIA with SHARESOURCE represents Baxter's continued commitment to advancing renal technology that offers healthcare providers and patients therapy options for end-stage renal disease," said Jill Schaaf, president of Baxter's Renal business.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Medical Gadgets
A novel type of neural implant was found to restore limb function to amputees. The implant sheds insights into brain-machine interfaces.
The wearable sensor for muscle atrophy, the muscle condition can be used by an astronaut on a long mission to keep track of his health.
Newly developed custom 3D-printed heart replicas look and pump just like real human heart.
What is the market size for surgical robotics? The market size is expected to expand at a compound annual growth rate (CAGR) of 18.0% from 2023 to 2030.
Is the Apple Watch a life-saver? Yes, the Apple Watch 7 saves the wearer's life by alerting about fatal internal bleeding following a nap.